Grants and Contributions:
Title:
Design of a new pre-clinical model of post-traumatic osteoarthritis in rats.
Agreement Number:
993166
Agreement Value:
$123,000.00
Agreement Date:
Jul 15, 2022 - Aug 31, 2024
Description:
Many companies aim to develop injectable products to prevent or delay the development of certain diseases. These products must be tested in pre-clinical models in order to prove their efficacy and then obtain regulatory approvals to begin clinical trials. The objective of this project is to develop a pre-clinical model for one of these indications.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Laval, Quebec, CA H7L 5C2
Reference Number:
172-2022-2023-Q2-993166
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
810312223
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 153 days.
Amendment Date
Dec 15, 2023
Recipient's Legal Name:
Biomomentum inc.
Federal Riding Name:
Marc-Aurèle-Fortin
Federal Riding Number:
24065
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: